BSE filing, NSE: UBL. Summary written from the filing by ALFA Finder's alert engine.
United Breweries Ltd: key numbers
- Share price
- ₹1,206.70
- Market cap
- ₹31,906 Cr
- Revenue (annual)
- ₹9,240 Cr
- Net profit (annual)
- ₹413.2 Cr
- P/E (TTM)
- 65.9×Sector 25.3×
- Promoter holding
- 70.83%+0.00% QoQ
- FII holding
- 5.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from United Breweries Ltd
All →United Breweries Product Launch
United Breweries expanded availability of Heineken Silver, a premium mild lager, into Puducherry effective November 16, 2026. The launch is for the domestic market only.
United Breweries Earnings Call Transcript: Key Takeaways
UBL delivered strong revenue and EBITDA growth, driven by volume acceleration and premiumization, though results were flattered by an income tax refund.
United Breweries Q2 FY27 Results: Net Profit ₹134.8 Cr, Up 191.1% YoY
United Breweries Ltd reported revenue from operations of ₹4,623 Cr (+23.7% YoY) and net profit of ₹134.8 Cr (+191.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹134.8 Cr · +191.1% YoY
United Breweries Other Announcement
United Breweries Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
United Breweries Product Launch
United Breweries has launched 'Heineken Silver' beer in the state of Assam. This expansion makes the premium brand available to consumers in the region.
United Breweries Legal & Regulatory
United Breweries Limited received income tax refunds totaling ₹100.83 Crore for Assessment Years 2013-14 and 2020-21. These refunds, including interest, positively impact working capital.
- Value
- ₹100.8 Cr
Other regulatory approval announcements
All →Senores Pharmaceuticals Regulatory Approval
Senores Pharmaceuticals disclosed that its subsidiary Ratnatris Pharmaceuticals' Mehsana facility received PIC/S GMP certification from Ukraine's SMDC. The certificate, issued 16 November 2026, opens a wider pathway to regulatory approvals.
Xtglobal Infotech Regulatory Approval
XTGlobal received RBI approval for a ₹0.10 Crore (EUR 10,000) equity investment in its Irish subsidiary. The initial capital supports its European expansion plans.
- Value
- ₹0.10 Cr
Regal Entertainment & Consultants Regulatory Approval
Regal Entertainment received RBI approval for Satbir Singh's appointment as Executive Director. Shareholder approval is still pending, with the term running to April 4, 2028.
Biocon Regulatory Approval
Biocon received U.S. FDA approval for Pebrilzo (pertuzumab-qcay), a biosimilar to Perjeta, its fifth oncology biosimilar approved in the US. A global settlement with Genentech sets the earliest US launch in Q3 2028.
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Binimetinib tablets, securing 180 days of generic drug exclusivity for the product.
Bhageria Industries Regulatory Approval
Bhageria Industries received EDQM attestation of GMP inspection for its Vapi facility, confirming EU GMP compliance for Dexamethasone under CEP No. 2024-138. No monetary value is disclosed.